Nasal Provocation Test in the Diagnosis of Allergic Rhinitis by Graça Loureiro et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
10 
Nasal Provocation Test in 
 the Diagnosis of Allergic Rhinitis 
Graça Loureiro, Beatriz Tavares, Daniel Machado and Celso Pereira 
Immunoallergy Department, Coimbra University Hospital 
Portugal 
1. Introduction 
The specific provocation tests, since its introduction by Blackley in 1853, have been widely 
used in the investigation of pathophysiological mechanisms, immunological and 
therapeutic aspects of allergic disease, as they mimic the response to allergen exposure, 
under controlled conditions. However, it has not been broadly used in the diagnosis of 
allergic disease in clinical practice, because of the lack of standardization of the 
methodology and the need of other complementary diagnostic tests for monitoring 
specific provocation tests. Nevertheless, the importance of such test is enormous in many 
circumstances, since it is the only method that can establish the exact etiology of allergic 
disease. Although the usefulness of these tests has not been questioned, the need to 
standardize the methodology for monitoring the response has been stressed. In this 
review, these aspects will be discussed. 
2. Allergic rhinitis 
Rhinitis is generally subdivided into two groups: allergic and non-allergic. It has been 
estimated that allergic rhinitis has a high prevalence in the general population (5 to 20%), 
and non-allergic rhinitis alone is thought to affect more than 200 million people worldwide. 
So, this is a very common but under diagnosed disease. The correct diagnosis has an 
enormous impact in public health, since it would involve several health and economic 
benefits (Bousquet & ARIA Workshop Group, 2001). 
Allergic rhinitis is an IgE mediated inflammatory chronic disease affecting nasal mucosa, 
characterized by the presence of itching, rhinorrea, sneezing and congestion (Bousquet & 
ARIA Workshop Group, 2001). The diagnosis of allergic rhinitis is based mostly in clinical 
evidence. In fact, a positive correlation between the clinical history and the allergen 
sensitization is usually enough to support the diagnosis of allergic rhinitis and its aetiology. 
However, in some circumstances (table 1), additional approaches are required to reach a 
correct diagnosis in allergic rhinitis patients, namely nasal provocation test (NPT). Indeed, the 
specific NPT is the method of choice for the reproducibility of the allergic reaction, and it is 
indicated when discrepancies arise in the assessment of a patient’s medical history and the 
results of skin and/or serological tests, as reviewed by several authors (Litvyakova LI & 
Baraniuk JN. 2001; Loureiro, 2001; Dordal et al, 2011; Mellilo, 1997; Naclerio & Norman, 1998).  
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Clinical practice 
 Multissensitized patients 
 Local allergic rhinitis 
 Occupational allergic rhinitis  
 Correlation between allergy and other morbidities 
Investigational research 
 Mechanisms of allergic reaction  
 Mechanisms of immunotherapy 
 Efficacy of new treatments  
Table 1. Indications for NPT: clarifying the pathogenesis and diagnostic evidence, in 
particular situations of allergic rhinitis 
2.1 Multissensitized patients 
Atopic patients are frequently sensitized to multiple allergens. In some circumstances, 
clinical history is not clearly related to allergen specific IgE. A NPT could be performed to 
differentiate the relevant allergenic aetiology in multissensitized patients, since these 
patients need specific therapeutic approaches. 
2.2 Local allergic rhinitis 
Patients with allergic rhinitis have allergen-specific IgE demonstrable both systemically as 
well as local IgE produced in the nasal mucosa. On the other hand, the concept of non 
allergic rhinitis is supported by negative skin tests. However, in a subset of patients who 
have positive NPT to allergens despite having a negative skin prick test, it has been 
hypothesized that these patients have localized allergic rhinitis. Huggins made the first 
description of local allergic rhinitis (Huggins & Brostoff J, 1975). Recently, several studies 
have strengthened the existence of this allergic disorder and the immunological mechanisms 
involved in the immediate and late responses to NPT have been described (Kim & Jang, 
2010; López S et al, 2010; Rondón et al, 2007, 2009, 2010a, 2010b). A type 2 helper T cell 
inflammatory pattern in nasal secretions in response to allergen exposure was 
demonstrated. Accordingly, local production of IgE and mast cell / eosinophil activation 
with its inflammatory mediators was also founded in these patients. These findings support 
the hypothesis of a localized inflammatory response and the concept of local allergic rhinitis. 
As discussed, local allergic rhinitis involves nasal production of specific IgE in the absence 
of atopy. Evidence of this entity is supported by suggestive clinical symptoms and a positive 
NPT. So it is a useful tool for detecting patients with local allergic rhinitis in previously 
diagnosed idiopathic / non-allergic rhinitis patients, as defended by several authors and 
evidenced by our group (Loureiro et al, 2011). In our experience, the specific NPT 
reproduced the clinical manifestations in some patients, supporting the concept of local 
allergic rhinitis in a subset of patients with perennial rhinitis. We studied 15 patients with an 
average age of 22.2±14.8 years (77.7% were female) with typical clinical symptoms of 
perennial rhinitis, negative skin prick test to common aeroallergens and negative specific 
IgE. The period of symptoms evolution was 5.37±3.9 years. A Dermatophagoides specific NPT 
(BialAristegui, Bilbao, Spain) was performed with clinical monitoring. Total nasal symptom 
scores were assessed using a validated questionnaire and a positive NPT was considered if a 
score of 5 or greater was recorded (Linder, 1988). The NPT was considered positive in 8 
patients. Several studies proved that house dust mites could have a pro-inflammatory 
activity independent of IgE (Fujisawa et al, 2008; Gregory et al, 2009; Hammad et al, 2009; 
Wong et al, 2006). This fact could explain the positive result in NPT, in our study however, 
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all patients were negative to a non-specific NPT. Despite the few number of patients 
included, our data highlight the need for the most complete diagnostic approach. The 
correct differential diagnosis with non-allergic rhinitis is crucial for therapeutic purposes, 
since some of these misdiagnosed patients may benefit of specific immunotherapy. Indeed, 
in our findings, all the patients with the diagnosis of local allergic rhinitis were submitted to 
specific immunotherapy, with clinical improvement (data not published).  
Because the concept of local allergic rhinitis is based in positive NPT, some authors 
emphasize the need to standardize this procedure to better understand its usefulness in the 
diagnostic approach of this new entity. It has still controversial aspects to be defined, as 
discussed by some authors (Alvares & Khan, 2011; Khan 2009). In a review of the studies 
that evaluated patients with negative skin tests using NPT, these authors argued that several 
aspects could explain the different data in the literature. For instance, the prevalence ranges 
from 0% to 100% of skin test negative individuals. This wide range in prevalence could be 
explained by the differences in methodology (allergen manufacturers, concentrations, and 
numbers of allergens tested) and, perhaps most importantly, criteria for a positive nasal 
challenge. In another review of the literature, the concept of entopy was also considered 
controversial (Forester & Calabria, 2010). In spite of this, they recognize that there are a large 
number of non-allergic rhinitis patients for whom current treatment regimens are 
suboptimal, considering the need to better understand the subjacent immunological 
mechanisms to achieve an optimal diagnosis and treatment in this subset of patients. 
2.3 Occupational allergic rhinitis 
The occupational exposure to immunogenic substances, such as chemicals and biologic 
products is enormous in the workplace, since it is the place were people spend more time. 
Despite an increasing estimated prevalence of 5 to 15%, occupational allergic diseases, 
namely occupational rhinitis it is still underestimated. Several factors are pointed, including 
the worker reluctance to complain and the failure to diagnose. More than 400 substances 
have been implicated as cause of occupational respiratory allergy. It is recognized that 
exposure to these substances can result in increased nasal hyperreactivity and can 
predispose to occupational rhinitis. It presents a major impact in quality of life, as well in 
professional performance. Further the legal impact, a correct etiologic identification in 
occupational allergic rhinitis as an enormous impact in the natural history of this disease. 
Indeed it is assumed that occupational rhinitis coexists and it may precede occupational 
asthma. Despite this, occupational asthma has been better evaluated than occupational 
rhinitis, both in epidemiological and physiopathological approaches.  
The real incidence and prevalence of occupational disease is not known. Occupational 
disease has been recognized by physicians and epidemiologists. However, there are a few 
publications about occupational rhinitis. NPT is an fundamental diagnostic approach of 
occupational Allergic Rhinitis (Loureiro, 2008). 
New allergens (high molecular weight as well as low molecular weight agents) are 
continuously being described in occupational asthma and/or rhinitis. Standardized extracts 
for skin testing are not available. A complementary diagnostic approach in occupational 
rhinitis, to better recognise and early diagnose this disease, includes specific NPT with 
clinical and functional monitoring. In fact, NPT is the ideal methodology to confirm or 
refute the diagnosis of occupational allergic rhinitis because it confirms the clinical 
symptoms and its causality. For instance, using NPT our group could reached the correct 
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etiologic diagnosis of the first case of fungal lipase allergy in a patient not sensitized to 
amylase working in the pharmaceutical industry (Loureiro, 2009). It has well known that 
occupational allergy to lipase has been reported in the detergent industry (Brant et al, 2004, 
2006; Lindstedt et al, 2005; van Kampen et al, 2000). While the main allergenic enzyme in the 
pharmaceutical industry is amylase, there have been reports of lipase sensitization, albeit 
without clinical relevance (Park et al, 2002; Zentner et al, 1997). The NPT was the supporting 
approach methodology to obtain this diagnosis confirmation, in our patient. Several cases of 
occupational allergic rhinitis are described in the literature, based directly on positive NPT, 
both in confirming the diagnosis and the etiological identification. The NPT reproduces the 
nasal symptoms and can be performed on the workplace, or under controlled conditions in 
hospital environment (Gosepath et al, 2005; Hytonen & Sala 1996; Hytonen et al, 1997; 
Litvyakova & Baraniuk, 2001; Loureiro, 2008). In a relevant study, 507 NPT were performed 
in 165 patients and the authors concluded that NPT is an essential, easy and safe tool in the 
diagnosis of allergic occupational rhinitis (Airaksinen et al, 2007). Recently, there has been a 
growing scientific interest in work-related rhinitis, because the relationship to asthma has 
been evaluated (Vandenplas, 2010). Considerations of the epidemiology of work-related 
rhinitis (both occupational rhinitis and work-exacerbated rhinitis) and its medico-legal 
implications have stressed the need to better identify this entity. Recent consensus have 
been presented to better define, classify and diagnosis occupational rhinitis, emphasizing 
the importance of NPT (EAACI Task Force on Occupational Rhinitis, 2008; Moscato et al, 
2011; Dordal et al, 2011). 
2.4 Investigational research 
The applicability of NPT on investigational research is widely described in the literature, 
namely in the study of several aspects of allergic disease, namely the mechanisms of allergic 
reaction, the mechanisms of immunotherapy, the efficacy of new treatments and also in the 
study of the link between allergy and other morbidities, namely ENT diseases.  
In a prospective controlled study, the possible role of nasal allergy in chronic disease of the 
maxillary sinuses was evaluated using NPT combined with radiography and ultrasonography 
(Pelikan, 2009). It was concluded that nasal allergy might be involved in some patients with 
chronic sinusitis. In these patients the NPT was a useful diagnostic tool and allowed to achieve 
a better diagnostic of co-morbidity and, consequently, therapeutic measures. 
Otitis media with effusion (OME) is a very prevalent disease, particularly in children. The 
OME pathogenesis is considered multifactorial, and it has been related to viral upper 
respiratory tract infection and eustachian tube disfunction. Allergy has been implicated in 
OME pathogenesis by several authors, but it is a matter still controversial. It has been 
assumed that there is insufficient evidence of therapeutic efficacy or a causal relationship 
between allergy and OME. For instance, 123 children with OME (and 141 controls) were 
submitted to NPT. The prevalence of the allergic rhinitis in children with OME did not differ 
significantly when compared to control subjects, and the abnormalities in Eustachian tube 
function were the same in both groups (Yeo et al, 2007). A recent review of literature 
pointed to a strong possibility of allergy as a risk factor for OME. Thus patients with allergic 
rhinitis should be evaluated for OME and patients with OME should be considered for an 
allergy evaluation. Allergy should be treated aggressively in these patients, because OME 
has important and severe sequelae (Lack et al, 2011; Skoner et al, 2009). Our group studied 
34 children with diagnosis of adenoids hypertrophy with or without OME, with 7.601.76 
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years. They were submitted to skin prick test with common aeroallergens battery. 24 were 
sensitized to Dermatophagoides pteronyssinus. The link between allergy and OME was 
evaluated in each patient with Dermatophagoides pteronyssinus specific NPT (BialAristegui, 
Bilbao, Spain). The NPT was monitored using symptom scores and it was considered 
positive if a total score ≥ 5. The NPT was positive in 20.8% of the sensitized children. The 
therapeutic management of these patients included immunotherapy with clinical 
improvement, supporting the link between allergy and OME in a subset of patients.  
Concerning investigational research in the yield of the allergic disease, NPT has been widely 
used to better understand the underlying mechanisms. Pereira C, 2009 showed that the cell 
response starts at an early stage, in parallel with the immediate allergic response. The IgE 
mediated response induces immunolymphatic involvement of the adjacent structures. This 
amplifies the allergic response to locoregional lymphoid organs, while leukocyte 
recirculation involves the primary lymphoid organs (thymus and bone marrow). These 
central organs are responsible for the systemic immune response induced by a focused 
allergen challenge, in this case, a nasal challenge. 
3. Nasal provocation test  
The NPT is an “in vivo” diagnostic method that mimics the allergen natural exposure. The 
allergic reaction is triggered by allergenic exposure, and symptoms are recorded. Although 
not standardized, it is an extremely helpful method as it has several important indications in 
the diagnosis of allergic rhinitis (table 1), as described above. Indeed, specific allergen 
challenge tests are still the gold standard for allergic diseases diagnosis, being an important 
tool to assess the treatment outcomes. Moreover, they have been essential in research, 
namely in the progressive understanding of the pathophysiology, immunology and 
pharmacotherapy of allergic diseases.  
The first allergen challenge was performed in 1873, by Blackley, who elicited a nasal 
response after an application of fresh pollen to the membrane of his own nostrils (Blackley, 
1873). After this first NPT, several consensus and guidelines have been published trying to 
achieve a better diagnostic approach of allergic disease and its knowledge (Dordal et al, 
2011; Druce & Schumacher, 1990; Gosepath et al, 2005; Litvyakova & Baraniuk, 2001, 2002; 
Lund et al, 1994; Malm et al, 2000; Mellilo et al, 1997; Schumacher, 1992). 
3.1 Methodology 
The anterior section of the inferior turbinate allows direct and visible application of the 
allergen extract, with consequent allergic reaction development (Dordal et al, 2011; 
Litvyakova & Baraniuk, 2001; Melilo et al, 1997; Naclerio & Norman, 1998). Despite the 
availability of the published international consensus guidelines, several difficulties are 
described in the assessment of the technique standardization, namely the type of allergen 
extracts to be used (lyophilized, aqueous or paper disc), the dose of allergen (which defaults 
to increase the doses) and the technique of administration of allergen (drops, micropipette to 
extract volumes, paper disks impregnated with solutions, nebulized extracts). The NPT 
should only be performed after a pharmacological washout period, namely H1- 
antihistamines, benzodiazepines, corticosteroids and mastocyte stabilizers. It should be 
performed at least 4 weeks after an undercurrent infectious disease and avoidance of 
exercise. Room conditions of temperature and humidity must be fulfilled. Aqueous solution 
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and lyophilized powder are the most common commercial allergen extract presentations. In 
most studies it is administered unilaterally by various methods: spray (without propellant 
gas), instillation (pipette, dropper, syringe) or application of small pieces of cotton or paper 
discs with impregnated allergen. The use of different concentrations is recommended, 
therefore the dose-response could be evaluated and hence the real sensitivity to that allergen 
can be assessed. The starting dose for the NPT must be calculated from the minimum 
concentration used for skin prick tests that induces a wheal diameter of 3mm. Alternatively 
the initial concentration recommended could be 1 / 100 of the concentration that induced a 
positive skin prick test. After establishing the initial concentration, it should be scheduled a 
progressive increment of doses. All NPT should be initiated with the previous 
administration of saline, to evaluate a possible irritant effect. The interval between 
administrations of the allergen at different concentrations should be performed in 15 to 60 
minutes. The terminus of the procedure occurs when there are symptoms of rhinitis or signs 
of mucosal inflammation. The application of the allergen must occur at the level of the 
previous section of the inferior turbinate, which is easily accessible, while the patient is 
asked a nasal expiration. The duration of expiration is not established, but the objective is to 
minimize bronchial inhalation. Several reviews in the literature analyse a variety of 
techniques and approaches, dosing and concentration of allergen extracts, delivery systems, 
and also the outcome-evaluation method (Dordal et al, 2011; Litvyakova & Baraniuk, 
2001,2002; Tantilipikorn et al, 2010). In our experience we used commercial extracts 
prepared in an aqueous solution administered as a spray, directly to the anterior section of 
the inferior turbinate. The starting dose for the NPT was the concentration that induced a 
wheal diameter of 3mm in each patient. 
3.2 Monitoring 
The response to NPT is clinical and laboratory assessable. Several parameters could be used to 
evaluate the immediate and late allergic response, namely the symptoms score, the evaluation 
of nasal congestion (nasal Peak Inspiratory Flow Rate (nPIFR), rhinomanometry, acoustic 
rhinometry) and inflammatory cells / mediators analysis in nasal secretions, as reviewed in 
the published consensus. None of the methods that evaluate the response to NPT is 
standardized. In many publications the assessment of nasal response is based exclusively on 
symptom scores. Some authors suggested objective measurements together with symptom 
scoring. Thus, the response to NPT should be determined by the combination of symptom 
scores and / or rhinomanometry (Dordal et al, 2011; Litvyakova & Baraniuk, 2001). 
3.2.1 Clinical symptom scores 
Despite symptom scores is a qualitative and subjective method, it is the most used to 
evaluate the response to NPT, both in clinical practice and investigational research, since it 
mimics a spontaneous allergic response. To assess the nasal response to NPT, it could be 
used a score based on a visual analog scale (Bachert, 1997) or scales of semi-quantitative and 
subjective clinical assessments (Lebel et al, 1988; Linder, 1988). Usually our group uses the 
symptom scoring scaling according to Litvyakova & Baraniuk, 2001. Simple rating scales 
from 0 to 3 are used, for each nasal or non-nasal symptom, with defined criteria such as 0 = 
no symptoms, 1 = mild symptoms (symptoms that are present but not particularly 
bothersome), 2 = moderate symptoms (symptoms that are bothersome but do not interfere 
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with daily activities), and 3 = severe symptoms (symptoms that are bothersome and 
interfere with daily activities or disturb sleep). Even though the known individual 
variability and the variability between patients, several authors have been tried to 
standardized the symptom score. In all reports, symptom scores are compared with 
objective parameters, supporting the relevance of the use of the symptom score in the 
monitoring of NPT. For instance, 155 patients with allergic rhinitis to Dermatophagoides were 
submitted to NPT to evaluate the optimal cut-off values of symptom changes after NPT for 
predicting perennial allergic rhinitis, as well as the nPIFR evaluation (Chusakul et al, 2010). 
In another study, the symptom score change and acoustic rhinometry values were 
combined, before and after NPT in 208 patients with allergic rhinitis and in 222 controls 
(Kim & Jang, 2011). 
3.2.2 Methods to evaluate nasal congestion: Nasal Peak Inspiratory flow rate, 
rhinomanometry and acoustic rhinometry 
The assessment of nasal congestion could be evaluated by subjective parameters (symptom 
score) and by an objective and quantitative method. Several techniques are available for 
assessing changes in nasal airflow resistance, patency, and nasal cavity geometry. Such 
techniques provide objective measurement of nasal congestion, namely nPIFR, 
rhinomanometry and acoustic rhinometry. These methods provide an objective and 
quantitative measurement whose value is based on the comparison of results over procedures 
(diagnostic or therapeutic) in each individual. In spite of this, standardized methodologies 
assessing functional abnormalities are not sufficiently developed (Nathan et al, 2005). 
Comparison of results between different patients is not yet standardized. Recently, several 
studies have been tried to standardize these methods as they can be useful in clinical practice 
and applied as a diagnostic tool in allergic rhinitis (Chusakul et al, 2010; Kim & Jang, 2011). 
Nasal Peak Inspiratory Flow Rate. This technique assesses the nasal airflow. It is easy to 
perform and inexpensive, but it is difficult to reproduce because is partially dependent on 
lung capacity (Wihl & Malm, 1988). Some studies demonstrated that nPIFR values correlate 
with airway resistance, but this is impracticable in case of intense rhinorrea (Holmstrom et 
al, 1990; Jones et al, 1991). 
Rhinomanometry. This standardized technique measures the resistance to the airflow in nasal 
cavities (Schumacher, 1989). Increases in resistance in one or both nasal cavities have been 
considered as an objective parameter in positive responses to NPT (Clement, 1984; Kirerleri 
et al, 2006). The technique depends on patient cooperation and it cannot be used in cases of 
septum perforation, intense rhinorrhea or nasal obstruction (Nathan et al, 2005).  
Acoustic rhinometry. This is a sound-based technique used to evaluate the nasal geometry, 
which measures nasal cavity area and volume. It has been validated by comparison to 
measurements with computed tomography and magnetic resonance imaging. It is used to 
diagnose and evaluate therapeutic responses in conditions such as rhinitis and to measure 
nasal dimensions during NPT (Keck et al, 2006; Kim et al, 2008; Uzzaman et al, 2006). 
Acoustic rhinometry is easy to perform and reproducible, but there are no reference values 
(Corey et al, 1998). It requires little cooperation from the patient, so it could be a useful 
method for children, and it is not affected by the presence of rhinorrhea or intense nasal 
obstruction. However, it cannot be applied in cases of septal perforation. Some 
interpretation caution should be made, when assessing changes in NPT. The nasal cavity 
volume between 2 cm and 6 cm is the most important parameter, because it corresponds to 
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the head of the turbinate, while the nasal cavity volume between 6 cm and 10 cm provides 
information about the sinuses and ostia. The intrinsic bias of the nasal cycle should not be 
overlooked, consequently, the cross-sectional areas and volumes of both nasal cavities 
should be measured after NPT (Gotlib et al, 2005). 
When comparing both techniques, acoustic rhinometry does not seem to be a better 
diagnostic method than active rhinomanometry in the monitoring of NPT (Keck et al, 2006). 
3.2.3 Laboratorial measurements: Inflammatory allergic mediators and cells 
The analysis of nasal cytology is essential to distinguish non-inflammatory from 
inflammatory nasal diseases. Additionally, the pattern of inflammatory mediators reflects 
the underlying immunological response. So the analysis of these inflammatory allergic 
mediators and cells are useful in the assessment of the response to NPT, namely in the 
diagnosis of allergic disease and in the evaluation of the treatment efficacy. Indeed, the NPT 
has been used to characterize and to clarify the immunological mechanisms involved in 
allergic reaction, and reciprocally, known inflammatory allergic mediators and cells have 
also been used to diagnose allergic rhinitis (for example local allergic rhinitis, as mentioned 
above) and to monitor the response to NPT. Allergic rhinitis is an allergen-induced IgE-
mediated inflammatory disease of the nasal mucosa. Several inflammatory mediators 
(histamine, tryptase, ECP, leucotrienes, cytokines and chemokines) are involved and the 
cellular infiltrate is characterized of mast cells, basophils, eosinophils and T cells. The 
usefulness of nasal cytology depends on several factors, namely obtaining adequate 
specimens, appropriate samples staining, and the materials interpretation. 
3.2.3.1 Methods to collect nasal samples 
Various techniques have been used for obtaining, processing, evaluating, and interpreting 
nasal specimens. The different methods for collecting samples are nasal lavage, nasal swab, 
nasal brushing, nasal curettage, nasal biopsy and collection of nasal secretions, allowing the 
assay of cells and inflammatory mediators. Several comparative studies show the usefulness of 
these non-standardized different methods. Each technique has advantages and disadvantages, 
so the selection of each method must be carefully decided. Description of the different 
techniques was reviewed elsewhere, in detail. (Dordal et al, 2011; Howarth et al, 2005). 
Nasal lavage. Naclerio first described this technique (Naclerio et al; 1983). This is a frequently 
used method to collect and to identify cells and inflammatory mediators. It has been used in 
research studies. In addition to nasal lavage, the collection of nasal secretions could be 
analyzed to look for both cellular and inflammatory mediators. 
Nasal brushing and Nasal biopsy should be performed on the inferior turbinate, to obtain 
cellular samples. Nasal brushing is usually performed at the middle third of the inferior 
turbinate, with easy sampling of the superficial of nasal mucosa. Nasal biopsy is usually 
performed on the lower part of the inferior turbinate, requires anaesthesia, and reaches 
deeper tissues. However it cannot be systematically repeated because it is traumatic. 
3.2.3.2 Difficulties in assessment of inflammatory response 
These techniques helped to attain the actual knowledge about the characteristics of allergic 
disease. However, its usefulness in the evaluation of the response to NPT is restricted to 
research trials, in order to better understand immunological allergic mechanisms and effects 
of new therapies. In clinical practice, the assessment of these inflammatory parameters is not 
enough to evaluate the response to NPT.  
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In our Immunoallergy Department, we performed a study to evaluate the concentrations of 
the chemokines, eotaxin and RANTES, in nasal lavage and analyze the applicability of the 
determination of chemokines in nasal secretions as a parameter of immune response to 
specific nasal provocation test (Loureiro et al, 2003). We included 17 patients with allergic 
rhinitis to Parietaria judaica (64% male; 36.311.2 years old). All the patients were submitted 
to NPT with Parietaria judaica commercial extract (Leti, Madrid, Spain) outside the pollen 
season. Nasal lavages were performed, before, 30 minutes and 6 hours after NPT, for 
quantification of inflammatory mediators. NPT response was monitored through symptom 
score. The NPT was positive in all patients, reproducing the clinical reactivity to the 
allergen, with a peak in the symptom scores at the first minute with subsequent decreasing 
till the sixth hour. Eotaxin was not measurable in any of the nasal lavage specimens 
collected. The chemokine RANTES levels were 4.2±2.1pg/ ml before NPT and 3.96±0.98 
pg/ml and 3.90±0.99 pg/ml in the specimens collected at 30 minutes and 6 hours after NPT 
respectively. These results did not correlate with symptoms progression during NPT. This 
could be interpreted as a discrepancy between the time of sampling and the dynamics of 
inflammatory mediators in response to NPT.  
In the same group of patients, during the same procedure, we also analysed the tryptase and 
ECP levels, in nasal lavage, as immunological markers of immediate and late response in 
allergic reaction, respectively (Loureiro et al, 2004). Tryptase was detected in only three 
patients. Nasal brushings were also performed to harvest cells. Cellular phenotyping (CD3, 
CD4, CD8 and CD 125) was assayed by flow citometry, before and 6 hours after NPT, to 
recognize the cellular dynamics during NPT. Our findings showed an increase in CD3 and 
CD8 cells in all patients. In a subset of patients submitted to immunotherapy we observed a 
CD4 cells increase and a CD125 cells decrease, after NPT, while the other patients not 
submitted to immunotherapy does not showed any dynamic alterations in these cells (figure 
1). The differences observed in each group could be explained by different therapeutic 
approaches in each group. However the dynamic cellular changes after NPT were not as 
expected. These findings could be explained by premature sampling before cellular 
trafficking occurred. Another possible explanation is the insufficiency of these sampling 
methods to harvest the sufficient cellular infiltrate. 
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(a) (b) 
Fig. 1. Nasal cell typing before and after nasal provocation test (NPT) (% of cells): A - in a 
group of patients submitted to immunotherapy for one year; B - in a group of patients not 
submitted to immunotherapy (Legend:  - CD3; - CD4; -CD8; - CD125) 
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In another study conducted by our group, 21 allergic patients were submitted to 
Dermatophagoides pteronyssinus specific NPT (BialAristegui, Bilbao, Spain). Secretions, 
namely tears and nasal secretions, were collected after NPT and inflammatory mediators, 
such as interleukins and chemokines were measured (data not published). These 
inflammatory mediators were measurable only in 21% of the tear samples and in 71.5% of 
the nasal secretion samples. According to these findings, nasal secretions recovery could be 
acceptable to be considered as an objective tool in the evaluation of inflammatory mediators. 
However we could not find out a pattern of mediator release since the inflammatory 
mediators were inconsistently detected in the different samples. 
Although the analysis of immunological parameters has been described as an objective 
approach to monitor the response to NPT, in our experience, these laboratorial 
measurements are difficult to perform because of the scheduling of sampling. Additionally, 
the cost-effectiveness of these procedures does not allow its implementation in the clinical 
practice. It should be reserved to investigational research.  
3.2.4 Assessment on nasal Nitric Oxide 
Determination of nasal Nitric Oxide (nNO) provides an indirect measure of the 
inflammation of the nasal mucosa. A decrease in nNO levels with NPT coincided with 
maximal symptom intensity, in five patients with pollen-induced allergic rhinitis 
(Kharitonov et al, 1997). Although nNO promises as a diagnostic non-invasive management 
tool, its value in nasal pathology is still not clear, mainly due to the lack of standardization 
of the test. Different methods of measurement have been used in published studies and the 
results reported are not comparable (Dordal et al, 2011). 
3.3 Criteria for positive NPT 
Besides diverse combined criteria have been discussed in the literature none of them are 
standardized criteria to define NPT positivity. This is summarized in the Table 2. 
4. NPT as a diagnostic approach in respiratory allergy 
The first allergen provocation test was performed in 1873, by Blackley, who elicited a nasal 
response after an application of fresh pollen to the membrane of his own nostrils (Blackley, 
1873). Currently, the indications of NPT are widely known. In this manuscript, the 
applicability of NPT as a diagnostic tool of allergic rhinitis was discussed. But the usefulness of 
NPT is not restricted to the diagnostic approach of allergic rhinitis. Supported by the concept 
of “one airway, one disease”, several studies have pointed out that the NPT is a good alternative 
to Bronchial Provocation Test (BPT), even in the absence of nasal symptoms. In spite of BPT 
being a standardized diagnostic tool, it is not frequently used in clinical practice because of its 
technically and methodologically requirement. Indeed, NPT is safer and better tolerated 
 
Reference 
Assessment of nasal 
response Description of positivity criteria 
Hytonen et al, 1997 Symptom score 
Δ ≥ 4, considering Δ = (obstruction score 
+ rhinorrhea score) after NPT - 
(obstruction score + rhinorrhea score) 
Lebel B et al, 1988 Symptom score 
Lebel Symptom Score Scale: Positive if ≥ 
5 (maximum possible score 11 points) 
www.intechopen.com
 
Nasal Provocation Test in the Diagnosis of Allergic Rhinitis 
 
163 
Reference 
Assessment of nasal 
response Description of positivity criteria 
Linder A, 1988 Symptom score 
Linder Symptom Score Scale: Positive if 
≥ 5 (maximum possible score 13 points) 
Terrien et al, 1999 nPIFR assessment Fall in nPIFR ≥ 40% 
Cimarra & Robledo, 2001 Rhinomanometry Airflow resistance increases by 100% 
Valero & Picado, 2000 Acoustic rhinometry 
MCA and nasal cavity volume vary by 
25-30% 
Álvarez Eire et al, 2006 
Combined symptom 
score and nPIFR 
At least two of the following criteria: 
five sneezing, runny nose, nasal 
congestion documented by a decrease ≥ 
20% of nPIFR 
Gosepath et al, 2005 
Combined symptom 
score and 
rhinomanometry 
A 40% reduction in airflow at 150 Pa in 
active anterior rhinomanometry, 
regardless of the symptom score,  
or  
a 20% reduction of in airflow at 150 Pa 
with a symptom score of more than 2  
Rondón C et al, 2007 
Combined symptom 
score and acoustic 
rhinometry  
a 30% increase in the symptom score 
using a visual analog scale and a 30% 
reduction in nasal cavity volume by 
acoustic rhinometry 
Kim & Jang, 2011 
Combined symptom 
score and acoustic 
rhinometry 
1) symptom score change: more than 2 
points in the case of nasal obstruction 
and more than 1 point for the case of 
rhinorrea or itching; 2) more than 24.5% 
change of total nasal volume and 3) 
more than 20% change of the minimal 
cross-sectional area.  
Wihl, 1986 
Combined nasal 
secretions amount and 
nPIFR 
0.5 mL (0.5 g) of nasal secretion with 5 
or more sneezes and a >20% reduction 
in nPIFR  
Pirila & Nuutinen, 1998 
Combined nasal 
secretions amount, 
rhinomanometry and 
acoustic rhinometry 
30 minutes after NPT: 
100 mg of nasal secretion with a 15% 
decrease in MCA and 50% increase in 
nasal airflow resistance;  
60 minutes after NPT: 
210 mg of nasal secretion with a 30% 
decrease in MCA and 100% increase in 
nasal airflow resistance 
Ganslmayer et al, 1999 
Combined acoustic 
rhinometry and nPIFR 
29% decrease in MCA and 26% decrease 
in nPIFR  
Table 2. Some criteria do define NPT positivity, adapted from Dordal et al, 2011. 
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method in asthmatic patients than BPT (Hervás et al, 2011; Marcucci et al, 2007; Oddera et al, 
1998). So, NPT has been used to the diagnosis of asthma, as reviewed by Olive Pérez, 1997. 
Thus, based on the united airways disease concept, the NPT could be considered as a model of 
specific provocation test that is easy and quick to perform, in the demonstration of the 
immediate and late phase response of type I hypersensitivity reaction. It is well known that the 
nose is an integral part of the upper airway, and anatomically related to several airway 
structures, such as ears and paranasal sinuses, and as well the eyes. There is an 
epidemiological relationship between rhinitis and asthma. Rhinitis and asthma are often 
associated, rhinitis typically precedes the development of asthma and can contribute to 
insufficient asthma control (Compalati et al, 2010). On the other hand, in cross-sectional and 
longitudinal studies, the vast majority of patients with asthma have rhinitis, and rhinitis is a 
major independent risk factor for asthma (Togias, 2003). Treating allergic rhinitis would 
probably ameliorate other associated upper airway diseases such as acute rhinosinusitis, nasal 
polyposis, adenoidal hypertrophy, and OME (Marple, 2010). In addition to improve allergic 
rhinitis outcome, the treatment of subjacent inflammatory disorder reduces asthma-associated 
health care consuming. A close interaction between the nose and contiguous or distant organs 
was described and it has been progressively clarified, supporting this epidemiological and 
clinical relation (Baroody, 2011). The upper and lower airways are not anatomically and 
functionally distinct areas (Slavin, 2008). It is currently established that the impaired function 
of the upper airways causing nasal obstruction, retention of secretions, and disturbed 
conditioning of the inspired air plays an important role in the development of lower airway 
symptoms (Virchow, 2005). There are important relationships between both the nose and the 
paranasal sinuses and asthma. Apart from the intrinsic physiological interaction, extensive 
evidence exists to sustain the concept that the respiratory system functions as an integrated 
unit (Krouse, 2008), where rhinitis and asthma are manifestations of one syndrome, the chronic 
allergic respiratory syndrome, in both parts of the respiratory tract (Togias, 2003). It has been 
described that parallel immunopathological processes involve the upper airway generally 
occur in conjunction with lower airway diseases, and diffuse inflammation often affects 
mucosal surfaces of the middle ear, nose, sinuses, and tracheobronchial tree simultaneously 
(Krouse, 2008). Recent studies show that the deposition of allergen into the lower respiratory 
tract leads to increased inflammation of the upper respiratory tract, even if the patients are 
only suffering from allergic rhinitis (Virchow, 2005). Additionally, studies indicate that 
treatment of the upper respiratory tract inflammation reduces the manifestation of allergen-
associated symptoms in the lower respiratory tract, and also have preventive effects if started 
early on the disease evolution (Bousquet & ARIA Workshop Group, 2001). Both asthma and 
allergic rhinitis have now been recognized as inflammatory diseases with similar 
manifestations in the mucous membranes of the upper (nose and paranasal sinuses) and lower 
respiratory tract (Virchow, 2005). There is increasing evidence that even in patients with 
rhinitis who do not have asthma, sub-clinical changes in the lower airways and inflammatory 
mediators can be detected (Compalati et al, 2010). These and other findings support that 
allergic diseases have a systemic component (Virchow, 2005). The interactive mechanisms of 
allergic rhinitis and associated conditions highlights the relevance of a bidirectional "unified 
airway" respiratory inflammation model. Currently, it is accepted that IgE mediated allergic 
reactions are not confined to the area where the trigger occurred, inducing a secondary 
systemic immune response (Braunstahl, 2005, 2006; Togias, 2004). The systemic inflammation 
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is produced after local allergic reactions (Togias, 2003). The link between local exposure to 
allergen and distant response has been clarified. Although some authors defend that this 
systemic response could result from allergen entering in the systemic circulation from the local 
of exposure (Hens et al, 2007) this could activate circulating basophils, inducing an 
anaphylactic reaction, which is a rare condition (Togias, 2004). Both systemic cell circulation 
and the nervous system activation are two major ways through which local allergic reactions 
propagate. Mast cell mediators locally released, increase the expression of adhesion molecules 
on postcapillary venules. This can lead to homing of circulating leukocytes, which may 
infiltrate distant tissues. This cell recirculation and focalization makes the IgE mediated 
allergic disease a dynamic and systemic process. Pereira C showed that this cell response starts 
at an early stage, in parallel with the immediate allergic response (Pereira, 2009). The IgE 
mediated response induces immunolymphatic involvement of the adjacent structures. This 
amplifies the allergic response to loco-regional lymphoid organs, while circulating leukocytes 
recirculation compromises the primary lymphoid organs (thymus and bone marrow). These 
central organs are responsible for the systemic immune response induced by a localized 
allergen challenge, in this case, a nasal challenge (Pereira, 2009). The nervous system activation 
could be involved by, any or both pathways, namely neurogenic inflammation and neuronal 
reflexes. Neurogenic inflammation is characterized by specific neuromediators closely related 
to neuro-immune-endocrine system, and it is both a stimulus to and a consequence of allergic 
inflammation. The naso-nasal and the naso-ocular reflexes are some examples of the role of the 
nervous system in the propagation of the allergic disease. They seem to be predominantly 
mediated by parasympathetic and cholinergic pathways, respectively (Baroody et al, 1994, 
2008). Histamine release during the acute response to allergen and substance P seem to have 
an important role in these neural mechanisms (Baroody et al, 1994, 2008; Fujishima et al 1997; 
Micera et al, 2008; O’Meara et al, 2005; Sheahan et al, 2005). Multiple evidences support a close 
interaction and influence of the nose on contiguous and distant organs via neural reflex and 
systemic inflammatory processes (Baroody, 2011). In summary, a local triggered allergenic 
inflammation is systematically extended, with the early connection of the immune central 
organs. Independently of the involved pathway, immediate symptoms are clinically 
manifested.  
Besides the limitations of NPT, this is a feasible and easily method to be performed, since 
the nasal cavities provide easy access to specific provocation. The concept of "One airway, one 
disease" allows assuming the similarity of response to the provocation of both the upper and 
lower airways, so the nasal allergic reaction could be accepted as predictor of bronchial 
response. Supported by the concept of the bidirectional "unified airway" respiratory 
inflammation, a local provocation test is useful in the diagnosis of allergic respiratory 
disease. Concerning these aspects, the NPT is the method of choice for the reproducibility of 
the allergic reaction (Litvyakova & Baraniuk, 2001; Loureiro, 2001; Mellilo, 1997; Naclerio & 
Norman, 1998). Thus the NPT may be considered a model of respiratory provocation test, 
easy to perform, in the demonstration of the immediate and late phase of type I 
hypersensitivity reaction. 
5. Characterization of NPT score symptom response  
According to all the mentioned above, the clinical symptom score is widely used in clinical 
practice, alone or associated to objective measurements of nasal obstruction, namely nPIFR, 
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rhinomanometry and acoustic rhinometry. The other methods, such as immunological 
measurements, should be reserved to research procedures related to the investigation of 
inflammatory network. However, due to the lack of standardization of parameters in the 
monitoring of NPT response, its reproducibility remains to be defined. The main problem 
includes the great variability of the responses in each patient and between patients. 
Although this is an important limitation, concerning NPT response interpretation, the 
symptom score has been used in the description of positive criteria to NPT response. 
As pointed out above, many authors use the symptom score as a method of monitoring and 
criteria for positivity in response to the NPT. According to the great variability in each 
patient and between patients, it has been assumed the absence of pattern of response to the 
NPT. The attempt to standardize this methodology was characterized by the symptom score 
quantification, through the use of symptoms scaling. One of the most important limitations 
of this symptoms scaling, is the overemphasis on nasal obstruction, since firstly not all 
patients value the perception of this symptom, and secondly, when it is present, it can result 
from concomitant obstructive and inflammatory causes. Besides there is no clinical pattern 
of response to NPT, our data showed a response profile, which can not be accepted as 
standard, but it can be useful in monitoring the NPT, namely in the evaluation of the 
dynamics of the response to NPT, as described bellow. 
5.1 Clinical symptom score pattern  
In our experience, the symptom score has supported the positivity of NPT. We analysed that 
the most frequent and intense symptoms occurred within the first 30 minutes after NPT, 
agreeing to immediate phase of allergic reaction. From all the studies conducted by our 
group, we did not observe a clinical score symptom pattern. However, we describe a clinical 
symptom score profile, which was frequent and was characterized by the presence of nasal 
and extra-nasal symptoms within the first 30 minutes, with a peak at 5 minutes.  
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Fig. 2. Score symptoms after Parietaria judaica specific nasal provocation test (NPT) (legend: 
 total score;  nasal score;  non-nasal score). 
Indeed, in a group of patients allergic to Parietaria judaica, as described above, specific NPT 
was performed and a symptom score was recorded. The figure 2 presents the total, nasal and 
non-nasal symptom scores. The higher total score of symptoms was recorded at the fifth 
minute with progressively decreasing symptoms till 30 minutes and then till 6 hours. Each 
nasal symptom followed this pattern. The non-nasal symptoms showed a different pattern, 
having a lower score, with similar values at both the fifth and the 30th minutes, followed by a 
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decline till 6 hours. Looking at the score of each nasal symptom (Figure 3), except for nasal 
obstruction, all of them followed the response pattern of total symptoms score, with a peak of 
symptoms at the fifth minute. Sneezing was the predominant symptom at the fifth minute, 
while nasal obstruction was the predominant symptom at the 30th minute and the sixth hour. 
 
0
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minutes
6 hours
 
Fig. 3. Nasal symptom score after specific Parietaria judaica nasal provocation test (NPT): 
evolution of each nasal symptom (Legend:  nasal congestion;  pruritus;  sneezing;  
rhinorrea). 
In another study mentioned above, the Dermatophagoides pteronyssinus specific NPT were 
performed in 34 children with OME. Those who had positive NPT, showed a response 
dynamics characterized by a rapid increase of symptoms score till a peak at the 5th minute 
(monitored till 1 hour), as shown in figure 4. Looking at the score of each nasal symptom 
(Figure 5), except for nasal pruritus, all followed the response pattern of total symptoms 
score, with the peak of symptoms at the fifth minute.  
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Fig. 4. Score symptoms after Dermatophagoides pteronyssinus specific nasal provocation test 
(NPT); (Legend:  total score;  nasal score;  non-nasal score). 
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Fig. 5. Nasal symptom score after specific Dermatophagoides pteronyssinus nasal provocation 
test (NPT): evolution of each nasal symptom (Legend:  nasal congestion;  pruritus;  
sneezing;  rhinorrea). 
Beyond the description of symptoms score obtained during NPT, it is also important to 
compare them with the usual symptoms described by the patient. This looks particularly 
relevant in the diagnosis of local allergic rhinitis.  
In our study related to local allergic rhinitis diagnosis, we included 15 patients with typical 
clinical symptoms of perennial rhinitis, negative skin prick test to common aeroallergens 
and negative specific IgE, as mentioned above (Loureiro G et al, 2011). The patients had an 
average age of 22.214.8 years, 77.7% were female. A Dermatophagoides pteronyssinus specific 
NPT was performed with clinical monitoring. Total nasal symptom scores were assessed 
using a validated questionnaire and a positive challenge was considered if a score of five or 
greater was recorded. NPT supported the diagnosis of local allergic rhinitis in a group of 
patients previously diagnosed with “non-allergic rhinitis”. They presented a period of 
symptoms evolution of 5.373.9 years. The symptom scores reported during natural 
exposure and after NPT are shown in figure 6. During natural exposure, the nasal total score 
was 6.22.05. Nasal congestion was always reported and it had the highest recorded value 
(2.80.35). The highest nasal recorded value during NPT was 6.42.19. Nasal congestion and 
pruritus were always reported and this second symptom had the higher recorded value 
(2.40.5). None of the 15 patients had conjunctivitis or asthma. Furthermore, in the 8 patients 
that had positive NPT, extra-nasal symptoms were recorded, namely conjunctival 
symptoms, oropharyngeal pruritus, cough and dyspnea, although with lower values.  
Concerning the occurrence of non-nasal symptoms, the major non-nasal symptoms 
observed were those localized in the conjunctiva, followed by oropharyngeal pruritus. 
Dyspnea and cough were recognized rarely. Non-nasal symptoms were documented in 20 
up to 100% of the positive NPT performed, considering the different studies conducted in 
our Immunoallergy Department.  
www.intechopen.com
 
Nasal Provocation Test in the Diagnosis of Allergic Rhinitis 
 
169 
Nasal congestion was
always reported and it
had the highest recorded
value (2.8±0.35)
During natural exposure, 
the nasal total score was
6.2±2.05
Nasal congestion and
pruritus were always
reported and the latest
had the higher recorded
value (2.4±0.5)
The highest nasal 
recorded value during
NPT was 6.4±2.19
Natural 
exposure
NPT
 
Fig. 6. Symptom scores reported during natural exposure and after nasal provocation test 
(NPT). 
5.2 Comparison of Dermatophagoides pteronyssinus nasal provocation test versus 
conjunctiva provocation test 
Our group and others authors have been using clinical scores to evaluate NPT response. 
According to our findings described previously, in respect to the symptoms scores pattern in 
response to NPT, we conducted a study to characterize the clinical response to NPT comparing 
to conjunctiva provocation test (CPT). As CPT is easy to perform and systemic reactions are 
uncommon, some authors have studied the concordance between NPT and CPT in the 
diagnosis of allergic rhinitis (Andersen et al, 1996; Leonardi et al, 1993; Malmberg et al, 1978; 
Petersson et al, 1986; Riechelmann et al, 2003) and asthma (Mosbech et al, 1987) using clinical 
score symptoms and/or objective methods. However, we are not aware of any publication 
describing the clinical pattern of NPT and CPT responses, neither about its comparison.  
Our aim was to compare the dynamics of clinical responses induced by NPT and CPT, using 
a clinical score system. 
5.2.1 Material and methods 
5.2.1.1 Subjects 
We studied two groups of voluntary adult patients, referred to our outpatient Immunoallergy 
Department, with Dermatophagoides pteronyssinus (Dp) allergic rhinitis/rhinoconjunctivitis 
with or without associated bronchial asthma, according to ARIA (Bousquet & ARIA 
Workshop Group, 2001) and GINA guidelines, respectively. All patients were clinically 
stable at the time of the study. Patients with past or ongoing immunotherapy for 
Dermatophagoides, an exacerbation of allergic disease or a respiratory tract infection in the 
last month, a nasal surgery in the last 3 months or nasal pathology such as polyps or a 
deviated nasal septum, were excluded. H1-antihistamines and costicosteroids, either nasal 
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or oral, were withheld for 2 weeks and 4 weeks prior to the challenge test, respectively. All 
patients underwent the challenge between January and February of 2009, a period of low 
natural exposure to mites in Portugal. A Dp NPT was performed in 21 patients and the 
conjunctival provocation test (CPT) was performed in the other 21 patients. The local ethics 
committee approved the study and all the participants gave written informed consent before 
entry. A respiratory function test (pletismography using Master screen Body Jaeger®) was 
performed by all the participants, before specific provocation tests, with all presenting a 
baseline FEV1  80% and FEV1/FVC  80. After provocation, all patients were asked for the 
presence of dyspnoea, thoracic oppression, wheezing or cough.  
5.2.1.2 Specific nasal and conjuctival provocation tests  
A skin prick test aqueous extract of Dp with a 5 mg/ml concentration (23 g/ml of Der p 
1, BialAristegui, Bilbao, Spain), with 1/1, 1/10, 1/100 and 1/1000 dilutions were 
performed; negative and positive controls were performed in all patients, according to 
standardized procedures (Dreborg & Frew A, 1993). The concentration used to specific 
provocation was the minimum that induced a prick test wheal at least equal to that 
induced by histamine, which curiously was the 1/10 dilution in all patients. Specific NPT 
with Dp extract were performed in the morning and after an adaptation to room 
temperature for 30 minutes, in both groups. NPT was performed with unilateral nasal 
application of 2 consecutives puffs (total volume of 160 l) of the Dp extract to the inferior 
nasal turbinate of the less congested nostril, using a nasal applicator spraying and patients 
were asked to perform apnoea during the allergen spraying. CPT consisted in unilateral 
ocular application of 1 drop (50 l) of the Dp extract in the inferior and external quadrant 
of the bulbar conjunctiva. Nasal and eye symptoms were recorded at the 1st and 5th 
minutes after specific provocation tests, using a clinical score system to assess the 
response (Linder A, 1988).  
5.2.1.3 Clinical score scaling 
Clinical responses were evaluated using a nasal clinical score (NCS) and an ocular clinical 
score (OCS), at the 1st and the 5th minutes. An adaptation of the previously used NCS 
(Linder A, 1988) and OCS (Mortemousque, 2007) were applied. A total clinical score (TCS), 
representing the sum of NCS (range: 0-15) and OCS (range: 0-13) was also used, ranging 
from 0 to 28 points. Rhinorrhea, sneezing, itchy nose, itchy ear/throat, nasal obstruction, 
watery eyes, redness of eyes and burning of eyes were rated on a scale from 0 to 3 points (0, 
none; 1, mild; 2, moderate; 3, severe). Itchy eyes were scored from 0 to 4 points (0, none; 1, 
mild; 2, moderate; 3, severe; 4, very severe). A positive response to NPT was considered 
when NCS 3 (Linder A, 1988) and to CPT when OCS 5 (Mortemousque, 2007). Clinical 
evaluation was interrupted after the 5th minute to collect humours for further investigation 
to determine inflammatory markers within a research investigation of immunologic 
mechanisms in allergic disease (Pereira, 2011, in press). 
5.2.1.4 Statistical analysis  
Statistical analysis were performed using SPSS® Statistics 17.0 software. Comparisons 
between NPT and CPT were studied using Chi-Square test. Intra-groups differences 
between the 1st and the 5th minutes after provocation were analyzed using a Mann-Whitney 
U-test. A statistical significant difference was assumed with p < 0.05. 
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5.2.2 Results  
Demographical and clinical data are presented in Table 3. Table 4 shows the number of 
patients that presented nasal and ocular responses at the 5th minute, induced by NPT and 
CPT, as well as the number of positive challenges at the 1st and the 5th minutes. A 
progressive increase in clinical score was observed in both provocations. The NPT 
progressive response was linear while for the CPT it was exponential, as shown in figures 7. 
CPT response was stronger than NPT at the 5th minute, achieving borderline significance 
(p=0.05). Clinical score results for NPT and CPT are shown in Table 5. 
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(a) (b) 
Fig. 7. Dynamics of symptoms score in response to: A – NPT (Linear progression); B – CPT 
(Exponential progression) Legend:  - Total Symptom score;  - Nasal symptom score;  - 
Non-nasal symptom score) 
The most frequent symptoms were nasal obstruction, itchy ear/throat and itchy nose, for 
NPT, and ocular hyperaemia and burning eyes, for CPT in all patients. In NPT, nasal 
obstruction was observed in 100% of the group. CPT induced ocular hyperaemia and 
burning eyes in all patients. There were neither bronchial symptoms nor systemic reactions 
in any of the provocation tests.  
The highest scores were reached by nasal obstruction and rhinorrhea in NPT and by ocular 
hyperaemia in CPT. The average intensity of each sign/symptom at the 5th minute is shown 
in figure 8. 
 
 NPT CPT 
n 21 21 
Average age (years) 28.0  9.0 28.1  5.7 
Gender ♀ (%) 57.1 66.7 
Rhinitis (n) 
Rhinoconjunctivitis (n)
20
1
16 
5 
Associated asthma (%) 42.8 90.5 
Cutaneous reactivity to Dp (mm) 
Specific IgE to Dp (KU/L)  
6.5  2.1 
29  24.9
8.6  3.6 
36.3  37.2 
Disease evolution (years) 13  10 12.3  8.5 
Table 3. Demographical and clinical data of patients submitted to NPT and CPT (Legend: 
NPT – nasal provocation test; CPT – conjunctiva provocation test) 
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 NPT CPT p 
Nasal response at 5th min 
Ocular response at 5th min 
21 (100%) 
10 (47.6%) 
20 (95.2%) 
21 (100%) 
ns 
0.0001 
Number of positive challenges: 
1st min 
5th min 
 
15 
21 
 
6 
21 
 
0.005 
Table 4. Frequency of nasal and ocular symptoms at the 5th minute and NPT and CPT 
outcomes at the 1st and the 5th minutes (Legend: NPT – nasal provocation test; CPT – 
conjunctiva provocation test; ns - not significant). 
Comparing NPT and CPT, in the first one the response was faster at the 1st minute (p=0.005) 
while for CPT it was stronger at the 5th minute (p=0.05).  
Although the inoculation of allergen was unilateral, NPT induced bilateral nasal symptoms 
in 100% and bilateral ocular symptoms in 47.6%. On the other hand, CPT induced unilateral 
ocular symptoms in 100% and bilateral nasal symptoms in 95.2%. There were neither 
bronchial symptoms nor systemic reactions. 
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Fig. 8. The average intensity of each sign/symptom at the 5th minute; (Legend:  - Nasal 
provocation test;  - Conjunctiva provocation test) 
5.2.3 Discussion 
Although the importance of the objective monitoring of specific provocation tests is 
unquestionable, its applicability in clinical practice is not always possible. Usually it is limited 
to the evaluation of only one symptom, such as nasal patency by nasal peak flow, acoustic 
rhinometry and/or rhinomanometry (Nathan et al, 2005); however it is not always the most 
perceived symptom by patients. Clinical scoring systems, even though more subjective, reflect  
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 NPT CPT p 
Total 
1st min 
5th min 
5th - 1st 
 
5.2  3.8 
9.9  4.4 
4.6  4.57 
 
4.7  3.6 
12.7  4.4 
8.0  3.87 
 
ns 
ns (0.05) 
0.011 
Nasal (NCS) 
1st min 
5th min 
 
4.28  2.6 
8.29  2.9 
 
1.24  2.1 
4.95  2.8 
 
<0.0001 
0.001 
Ocular (OCS) 
1st min 
5th min 
 
0.95  1.8 
1.57  2.3 
 
3.4  3 
7.7  3 
 
<0.0001 
<0.0001 
Table 5. Clinical score results for NPT and CPT (Legend: NPT – nasal provocation test; CPT 
– conjunctiva provocation test; ns – not significant). 
all symptoms, are easy and costless to apply in clinical practice. The validity and 
reproducibility of CPT based on clinical score systems were demonstrated in several studies 
(Abelson et al, 1990; Moller et al, 1984; Mortemousque, 2007; Rimas et al, 1992).  
According to our findings, we can describe a dynamic response profile to specific 
provocation. In our study, NPT response at the 1st minute was faster than CPT (p=0.005), 
with 15/21 patients presenting a positive NPT versus 6/21 patients with positive CPT. We 
speculate that this can eventually be explained by the existence of particular characteristics 
in nasal and ocular mucosa, resulting in differences related to the contact with the allergen 
and/or the time response of type I hypersensitivity. The NPT progressive response was 
linear whereas CPT one was exponential, till the 5th minute of response.  
On the other hand, CPT response was stronger at the 5th minute when comparing to NPT, 
achieving borderline significance (p=0.05). This corroborates other results related to the 
evaluation of patient discomfort of NPT versus CPT using a visual-analogue scale, with a 
higher discomfort being appointed to CPT (Riechelmann et al, 2003). Apparently, these 
results are different from the study of Malmberg et al, 1978, in which the conjunctiva of 55% 
of the patients that underwent both NPT and CPT, using sequentially diluted allergen 
solutions, was less sensitive to allergen challenge than nasal mucosa. However, the intensity 
of the positive CPT response was not described in this study. Our patients submitted to CPT 
had higher specific IgE values, but it is unlikely that this could explain the higher intensity 
symptoms score. The absence of a direct correlation between the degree of allergen 
sensitization and the severity of clinical symptoms is well known.  
As expected by direct allergen exposure, the higher intensity of nasal response was induced 
by NPT, while CPT was responsible for the higher intensity of ocular response.  
At the 5th minute, procedures to collect secretions were performed, and consequently the 
clinical evaluation of the response to specific provocation tests was disrupted. However, 
patients were clinically monitored till 4th hour. Interestingly, after the 5th minute, the 
intensity of the conjunctival response rapidly decreased while a similar intensity of nasal 
response persisted for a longer period. This data is not shown because the procedures for 
collection of secretions could alter the dynamic of response.  
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Even though the allergen was unilaterally inoculated, NPT induced bilateral nasal 
symptoms in 100% and bilateral ocular symptoms in 47.6%. On the other hand, CPT 
induced unilateral ocular symptoms in 100% and bilateral nasal symptoms in 95.2%. This is 
in accordance with previous studies and can be explained by different mechanisms 
mentioned above (Section 4. NPT as a diagnostic approach in respiratory allergy). An 
additional explanation for the higher number of patients with nasal symptoms induced by 
CPT, when comparing with the number of patients in whom NPT induced ocular 
symptoms, is the direct contact of the inoculated allergen with the nasal mucosa, through its 
passage via naso-lacrimal duct.  
This study describes, for the first time to our knowledge, the clinical patterns of NPT and 
CPT responses, using a clinical score system. NPT is faster than CPT and has a linear 
progression, while CPT has an exponential progression and has a stronger response. The 
induction of both nasal and ocular responses by NPT or CPT, corroborates the systemically 
response triggered by local allergen application. Although both methodologies can elicit 
extra-local symptoms, these are safe procedures. Finally, these data support the applicability 
of CPT in the diagnosis of allergic rhinitis, even in the absence of ocular signs/symptoms, 
surpassing some NPT limitations (such as nasal polyps or deviated nasal septum) and 
decreasing specific challenge risk.  
6. Conclusion 
The specific provocation tests have been widely used in the investigation of 
pathophysiological mechanisms, immunological and therapeutic aspects of allergic disease, 
since they mimic the response to allergen exposure, under controlled conditions. It is well 
known that NPT has limitations, but it has been helpful to a better clarification of the 
underlying mechanisms of allergic reaction, and also to recognize the systemic framework 
of allergic disease. The usefulness of NPT is focused in the diagnosis of allergic rhinitis itself, 
but it has also a relevant role in the diagnosis of allergic respiratory disease. The upper and 
lower airways do not exist as anatomically and functionally distinct areas. There are 
important relationships between both the nose and the paranasal sinuses, and asthma. These 
epidemiological, clinical and immunopathologic concordance between allergic rhinitis and 
asthma supports the concept of bidirectional "unified airway" respiratory inflammation 
model. Multiple evidence supports a close interaction and influence of the nose on 
contiguous and distant organs via neural reflex and systemic inflammatory processes. 
In clinical practice, NPT plays a central role in the diagnosis of allergic rhinitis in some 
circumstances, as described. This is the only method that could establish the correct 
aetiology of the allergic disease, namely local allergic rhinitis and occupational rhinitis. The 
specific therapeutic implications emphasize the attempt to reach the most complete 
diagnostic approach. 
The monitoring of the response to NPT is not standardized, but several parameters have 
been used, for example symptom scores. Our data suggest that the clinical symptom pattern 
to NPT develops has a dynamic response which is characterized by a linear progression of 
symptoms intensity till a 5th minute peak. The prevalence of non-nasal symptoms had a 
great variability in the studies performed by our group. Those symptoms had a lower score 
comparing to nasal symptoms. In our opinion, the symptom score is a valuable method to 
monitor the NPT response. 
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